Nightfood Holdings Inc. Pioneers Next-Generation Hospitality with AI and Robotics
Nightfood Holdings Inc. (OTCQB: NGTF) is setting a new standard in the hospitality industry by merging AI-powere
Find news articles quickly using keywords or date filters.
Use specific keywords or select a date range to narrow down your results.
Miami, Florida — October 9, 2026, Evertise AI PR, The U.S. Minority Chamber of Commerce proudly announces the affiliation of...
Lifestyle Expert Chassie Post features personalized midterm prep and smart home security, indulgent morning brews and effortless seasonal recipes to...
Built from inside the banking sector and collaboratively owned by the institutions it serves, Coin2Core earns a first-ever independent production...
Nightfood Holdings Inc. (OTCQB: NGTF) is setting a new standard in the hospitality industry by merging AI-powere
The Federal Energy Regulatory Commission (FERC) has granted approval for Constellation Energy Corporation's acquisitio
Homeowners in Pearland, Texas, seeking foundation repair services encounter a market where the quality and perma
HealthLynked Corp. (OTCQB: HLYK), a leader in healthcare technology, has unveiled its newly designed Enterprise Hea
GeoVax Labs, Inc. has embarked on a pioneering research program to assess the immunogenicity and stability of
Metavesco, Inc. (OTC: MVCO), a publicly traded diversified holding company, has strategically acquired 28 Ethe
Dropzone AI, a pioneer in AI SOC analysts, has successfully raised $37 million in Series B funding, with Theory
Dropzone AI, a pioneer in AI SOC analysts, has successfully raised $37 million in Series B funding, with Theory
A. Aubrey Bodine, celebrated as one of the twentieth century's finest pictorialists, left an indelible mark on the wo
A. Aubrey Bodine, celebrated as one of the twentieth century's finest pictorialists, left an indelible mark on the wo
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology company, has announced a 1-fo
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology company, has announced a 1-fo